OTCMKTS:PURE PURE Bioscience Q4 2024 Earnings Results & Report $0.07 +0.00 (+5.87%) As of 03:58 PM Eastern PURE Bioscience reported Q4 2024 earnings on October 29, 2024. The company reported EPS of -$0.01, while revenue was $0.47 million. Research:ProfileEarnings History Earnings Announcement Details QuarterQ4 2024Report DateOctober 29, 2024 PURE Bioscience EPS ResultsActual EPS-$0.01Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/APURE Bioscience Revenue ResultsActual Revenue$0.47 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile PURE Bioscience Q4 2024 Earnings FAQ Did PURE Bioscience beat earnings estimates for Q4 2024? PURE Bioscience (OTCMKTS:PURE) reported earnings of -$0.01 per share for Q4 2024. The report was announced on Tuesday, October 29, 2024. What was PURE Bioscience's revenue for Q4 2024? PURE Bioscience reported revenue of $0.47 million for Q4 2024. PURE Bioscience Earnings HeadlinesPURE Bioscience (OTCMKTS:PURE) Shares Cross Above Two Hundred Day Moving Average - Here's What HappenedOctober 14 at 3:01 AM | americanbankingnews.comPURE Bioscience (OTCMKTS:PURE) Share Price Breaks Above 200-Day Moving Average - Time to Sell?October 6, 2026 | americanbankingnews.comElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He points to a new AI project tied to Musk's Cybercab reveal. Brown says Musk has opened major investment windows before, with PayPal, Tesla, and SpaceX marking milestones in tech history. He believes a fourth may open by October 30.October 16 at 1:00 AM | Brownstone Research (Ad)Pure Bioscience Inc.August 12, 2026 | marketwatch.comPURE Bioscience Reports Fiscal Third Quarter 2026 Financial ResultsJune 15, 2026 | businesswire.comPurecore Strengthens Technical Advisory Expertise with Nuclear Fuel Cycle and Uranium Enrichment Specialist, Ted Rygas, PhDJune 15, 2026 | globenewswire.comSee More PURE Bioscience Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like PURE Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PURE Bioscience and other key companies, straight to your email. Email Address About PURE BiosciencePURE Bioscience (OTCMKTS:PURE), Inc. develops and commercializes antimicrobial products based on its proprietary silver dihydrogen citrate (SDC) technology. SDC is designed to provide broad-spectrum antimicrobial activity while serving as the active ingredient in disinfecting, sanitizing, and hygiene formulations. The company’s product portfolio has included PURE-branded solutions for hard-surface disinfection and sanitation, as well as applications in food safety, commercial and industrial settings, healthcare, and other environments where microbial control is important. Its products are intended for use on surfaces, equipment, and other areas requiring cleaning and antimicrobial protection. PURE Bioscience has historically marketed its products in the United States and has pursued additional commercial opportunities through distributors and strategic partners. The company is headquartered in California. Information about its current leadership and geographic operations is limited and may change over time.View PURE Bioscience ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Bank of America Stock Sell-Off Looks Like a Buying OpportunityMorgan Stanley Beats on Earnings, But Shares Fall on Trading MixFundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?Palantir's Potential Next Catalyst After Retail Profit-TakingApple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure Upcoming Earnings HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
